Skip to main content
ImmuneCited

Omega-3 Fatty Acids (EPA/DHA) para Chronic Inflammation

A

The VITAL trial and multiple randomized controlled trials demonstrate omega-3 fatty acids may help reduce CRP and modulate inflammatory cytokines. DHA showed stronger anti-inflammatory effects than EPA, lowering 4 pro-inflammatory proteins versus 1 in a randomized study.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dchronic\u002Dinflammation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Conclusión

The VITAL trial and multiple randomized controlled trials demonstrate omega-3 fatty acids may help reduce CRP and modulate inflammatory cytokines. DHA showed stronger anti-inflammatory effects than EPA, lowering 4 pro-inflammatory proteins versus 1 in a randomized study.

Key Study Findings

Review
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives.
Dose: None vs: None Outcome: None Efecto: None None

Población: None

Review
Proresolving Lipid Mediators in the Respiratory System.
Dose: None vs: None Outcome: None Efecto: None None

Población: None

Other
The omega effect: Harnessing fish oil for health.
Dose: None vs: None Outcome: None Efecto: None None

Población: None

Review
Medical Nutrition Therapy in Dermatological Diseases: A Joint Consensus Statement of the Italian Association of …
Dose: None vs: None Outcome: None Efecto: None None

Población: Patients with acne, HS, or psoriasis

Systematic Review
Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review.
Dose: None vs: None Outcome: Neurological health outcomes Efecto: None None

Población: None

Review
Immunomodulatory Effects of Omega-3 Fatty Acids: Mechanistic Insights and Health Implications.
Dose: None vs: None Outcome: None Efecto: None None

Población: review of omega-3 fatty acids' immunomodulatory effects

Key Statistics

30

Estudios

30000

Participantes

Positive

A

Calificación

Referenced Papers

Annual review of … 2025 13 citas
International immunopharmacology 2023 8 citas
Reproductive medicine and … 2020 11 citas
European journal of … 2016 102 citas
Clinical journal of … 2016 4 citas
Current atherosclerosis reports 2004 464 citas
Current atherosclerosis reports 2001 2 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
250-500 mg combined EPA/DHA/day
antiinflammatory:
1,000-3,000 mg combined EPA/DHA/day

Límite superior: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Positive --
None -- Mixed --
None -- Positive --

Mejor momento para tomar: With meals

Safety & Side Effects

Efectos secundarios reportados

  • Fishy aftertaste and burping
  • Gastrointestinal discomfort (nausea, diarrhea)
  • Increased bleeding risk at high doses
  • Potential LDL cholesterol increase at very high doses

Interacciones conocidas

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk)
  • Blood pressure medications (additive blood pressure lowering)
  • Orlistat (may reduce omega-3 absorption)
  • Cyclosporine (may modify immunosuppressive effects)

Ingesta máxima tolerable: 3,000 mg/day EPA+DHA (FDA-recognized as safe)

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Omega-3 Fatty Acids (EPA/DHA) help with Chronic Inflammation?
Based on 30 studies with 30,000 participants, there is strong evidence from multiple clinical trials that Omega-3 Fatty Acids (EPA/DHA) may support Chronic Inflammation management. Our evidence grade is A (Strong Evidence).
How much Omega-3 Fatty Acids (EPA/DHA) should I take for Chronic Inflammation?
Studies have used various dosages. A commonly studied range is 250-500 mg combined EPA/DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (EPA/DHA)?
Reported side effects may include Fishy aftertaste and burping, Gastrointestinal discomfort (nausea, diarrhea), Increased bleeding risk at high doses, Potential LDL cholesterol increase at very high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (EPA/DHA) and Chronic Inflammation?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 30 peer-reviewed studies with 30,000 total participants. The overall direction of effect is positive.

Related Evidence

Omega-3 Fatty Acids (EPA/DHA) para otras condiciones

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.